USA Market News

  Key Companies  Covered in the  Asia-Pacific Precision Medicine Market   Research are Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Into ics A/S., Biocrates Life Sciences Ag, and Pfizer Inc. and other key market players . The global Asia-Pacific Precision Medicine Market   size is projected to reach $7,746 million by 2031 from $3,516 million in 2022, at a CAGR of 11.9% during the forecast period . Kenneth Research has evaluated the current market opportunities in  Asia-Pacific Precision Medicine Market  in the healthcare industry for the forecast period  2022-2031,  which also includes the ongoing industry trends and innovations that will help industry players to attain their business targets. Apart from that, the inclusive data on market size, market share and forecast, growth opportunities and challenges for the market players, along with the worldwide analysis on regions- North America, Latin America, Europe,

  Kenneth Research published a report titled “ Enterprise Meta data Management Market : Global Demand Analysis & Opportunity Outlook 2031 ” which delivers detailed overview of the global enterprise metadata management market in terms of market segmentation by deployment, industry vertical, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. The global enterprise metadata management market is anticipated to attain a CAGR of ~15% over the forecast period, i.e., 2022 – 2031. The market is segmented on the basis of deployment into on-premise, and on-cloud, out of which, the on-cloud segment is anticipated to experience a significant growth over the forecast period. This can be accredited to cloud-based services being more prominent in businesses all around the world. Global clo